炎性反应在糖尿病神经病变发生中作用的研究进展

doi:10.16352/j.issn.1001-6325.2023.04.0669

基础医学与临床 ›› 2023, Vol. 43 ›› Issue (4): 669-673.doi: 10.16352/j.issn.1001-6325.2023.04.0669

炎性反应在糖尿病神经病变发生中作用的研究进展

蒋烨, 余卓颖^*, 李民^*

北京大学第三医院麻醉科,北京 100191

收稿日期:2022-06-23 修回日期:2022-12-26 出版日期:2023-04-05 发布日期:2023-04-03
通讯作者: ^*yingyiqing@126.com; liminanesth@bjmu.edu.cn
基金资助:
国家自然科学基金(82071411,82001329)

Research progress on inflammatory mechanism of diabetic neuropathy

JIANG Ye, YU Zhuoying^*, LI Min^*

Department of Anesthesiology,Peking University Third Hospital,Beijing 100191,China

Received:2022-06-23 Revised:2022-12-26 Online:2023-04-05 Published:2023-04-03
Contact: ^*yingyiqing@126.com; liminanesth@bjmu.edu.cn

摘要/Abstract

摘要： 糖尿病神经病变(DN)是糖尿病常见的并发症,目前机制尚不明确。近年来研究表明炎性反应在DN的发生中起重要作用。在糖尿病慢性低度炎性状态下,神经元及其周围细胞中的炎性信号通路被激活,与释放出的炎性因子相互作用,促进DN的发生。深入阐明DN的炎性反应机制,将有助于寻找新的治疗靶点。

关键词: 糖尿病神经病变, 炎性反应

Abstract: Diabetic neuropathy is a common complication of diabetes, but the mechanism remains unclear. Recent studies have shown that inflammation may play a critical role in the development and progression of diabetic neuropathy. In the chronic low-grade inflammatory state of diabetes, the inflammatory signaling pathways in neurons and their surrounding cells are activated and interact with the released inflammatory factors to promote the occurrence of diabetic neuropathy. Advances in the understanding of inflammatory mechanism will facilitate the discovery of the potential therapeutic targets for the development of diabetic neuropathy.

Key words: diabetic neuropathy, inflammation

中图分类号:

R587.2

蒋烨, 余卓颖, 李民. 炎性反应在糖尿病神经病变发生中作用的研究进展[J]. 基础医学与临床, 2023, 43(4): 669-673.

JIANG Ye, YU Zhuoying, LI Min. Research progress on inflammatory mechanism of diabetic neuropathy[J]. Basic & Clinical Medicine, 2023, 43(4): 669-673.

参考文献

[1]Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy[J]. Nat Rev Endocrinol, 2021, 17: 400-20.
[2]Hinder LM, Murdock BJ, Park M, et al. Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story[J]. Exp Neurol, 2018, 305: 33-43.
[3]Hall BE, Macdonald E, Cassidy M, et al. Transcriptomic analysis of human sensory neurons in painful diabetic neuropathy reveals inflammation and neuronal loss[J]. Sci Rep, 2022, 12: 4729. doi: 10.1038/s41598-022-08100-8.
[4]Rohm TV, Meier DT, Olefsky JM, et al. Inflammation in obesity, diabetes, and related disorders[J]. Immunity, 2022, 55: 31-55.
[5]胡贤良, 万燕, 冯霁. 肠道菌群在妊娠期糖尿病发病中作用的研究进展[J]. 基础医学与临床, 2022, 42: 516-519.
[6]Tran HQ, Bretin A, Adeshirlarijaney A, et al. “Western diet”-induced adipose inflammation requires a complex gut microbiota[J]. Cell Mol Gastroenterol Hepatol, 2020, 9: 313-333.
[7]Zhu D, Fan T, Huo X, et al. Progressive increase of inflammatory CXCR4 and TNF-alpha in the dorsal root ganglia and spinal cord maintains peripheral and central sensitization to diabetic neuropathic pain in rats[J]. Mediators Inflamm, 2019, 2019: 4856156.doi:10.1155/2019/4856156.
[8]Zhu D, Fan T, Chen Y, et al. CXCR4/CX43 regulate diabetic neuropathic pain via intercellular interactions between activated neurons and dysfunctional astrocytes during late phase of diabetes in rats and the effects of antioxidant N-acetyl-L-cysteine[J]. Oxid Med Cell Longev, 2022, 2022:8547563.doi:10.1155/2022/8547563.
[9]Paeschke S, Baum P, Toyka KV, et al. The role of iron and nerve inflammation in diabetes mellitus type 2-induced peripheral neuropathy[J]. Neuroscience, 2019, 406: 496-509.
[10]Agarwal N, Helmstádter J, Rojas DR, et al. Evoked hypoalgesia is accompanied by tonic pain and immune cell infiltration in the dorsal root ganglia at late stages of diabetic neuropathy in mice[J]. Mol Pain, 2018, 14:1744806918817975.doi:10.1177/1744806918817975.
[11]Sun JJ, Tang L, Zhao XP, et al. Infiltration of blood-derived macrophages contributes to the development of diabetic neuropathy[J]. J Immunol Res, 2019, 2019:7597382.doi:10.1155/2019/7597382.
[12]Thakur V, Sadanandan J, Chattopadhyay M. High-mobility group box 1 protein signaling in painful diabetic neuropathy[J]. Int J Mol Sci, 2020, 21: 881. doi: 10.3390/ijms21030881.
[13]Alomar SY, Gheit REAE, Enan ET, et al. Novel mechanism for memantine in attenuating diabetic neuropathic pain in mice via downregulating the spinal HMGB1/TRL4/NF-kB inflammatory axis[J]. Pharmaceuticals (Basel), 2021, 14: 307. doi: 10.3390/ph14040307.
[14]Sun Q, Zhang R, Xue X, et al. Jinmaitong alleviates diabetic neuropathic pain through modulation of NLRP3 inflammasome and gasdermin D in dorsal root ganglia of diabetic rats[J]. Front Pharmacol, 2021, 12: 679188. doi: 10.3389/fphar.2021.
[15]Sun Q, Wang C, Yan B, et al. Jinmaitong ameliorates diabetic peripheral neuropathy through suppressing TXNIP/NLRP3 inflammasome activation in the streptozotocin-induced diabetic rat model[J]. Diabetes Metab Syndr Obes, 2019, 12: 2145-2155.
[16]Zhang Q, Li Q, Liu S, et al. Glucagon-like peptide-1 receptor agonist attenuates diabetic neuropathic pain via inhibition of NOD-like receptor protein 3 inflammasome in brain microglia[J]. Diabetes Res Clin Pract, 2022, 186: 109806. doi: 10.1016/j.diabres.2022.
[17]Bhusal A, Rahman MH, Lee WH, et al. Satellite glia as a critical component of diabetic neuropathy: Role of lipocalin-2 and pyruvate dehydrogenase kinase-2 axis in the dorsal root ganglion[J]. Glia, 2021, 69: 971-996.
[18]Liu S, Liu X, Xiong H, et al. CXCL13/CXCR5 signaling contributes to diabetes-induced tactile allodynia via activating pERK, pSTAT3, pAKT pathways and pro-inflammatory cytokines production in the spinal cord of male mice[J]. Brain Behav Immun, 2019, 80: 711-724.
[19]Guo K, Eid SA, Elzinga SE, et al. Genome-wide profiling of DNA methylation and gene expression identifies candidate genes for human diabetic neuropathy [J]. Clin Epigenetics, 2020, 12: 123. doi: 10.1186/s13148-020-00913-6.
[20]Bali KK, Gandla J, Rangel DR, et al. A genome-wide screen reveals microRNAs in peripheral sensory neurons driving painful diabetic neuropathy[J]. Pain, 2021, 162: 1334-51.
[21]Fan B, Li C, Szalad A, et al. Mesenchymal stromal cell-derived exosomes ameliorate peripheral neuropathy in a mouse model of diabetes[J]. Diabetologia, 2020, 63: 431-443.
[22]Mert T, Sahin E, Yaman S, et al. Effects of immune cell-targeted treatments result from the suppression of neuronal oxidative stress and inflammation in experimental diabetic rats[J]. Naunyn Schmiedebergs Arch Pharmacol, 2020, 393: 1293-1302.
[23]Karonova T, Stepanova A, Bystrova A, et al. High-dose vitamin D supplementation improves microcirculation and reduces inflammation in diabetic neuropathy patients[J]. Nutrients, 2020, 12: 2518. doi: 10.3390/nu12092518.
[24]Zhang W, Yu H, Lin Q, et al. Anti-inflammatory effect of resveratrol attenuates the severity of diabetic neuropathy by activating the Nrf2 pathway[J]. Aging (Albany NY), 2021, 13: 10659-10671.
[25]Villarreal CF, Santos DS, Lauria PSS, et al. Bergenin reduces experimental painful diabetic neuropathy by restoring redox and immune homeostasis in the nervous system[J]. Int J Mol Sci, 2020, 21: 4850. doi: 10.3390/ijms21144850.
[26]Zhang X, Xia L, Xie A, et al. Low concentration of Bupivacaine ameliorates painful diabetic neuropathy by mediating miR-23a/PDE4B axis in microglia[J]. Eur J Pharmacol, 2021, 891: 173719. doi: 10.1016/j.ejphar.2020.

炎性反应在糖尿病神经病变发生中作用的研究进展

Research progress on inflammatory mechanism of diabetic neuropathy

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	孙莹, 杨治安, 何瑶, 余勤. HMGB1信号通路在支气管哮喘中作用的研究进展[J]. 基础医学与临床, 2023, 43(4): 690-694.
[2]	李立亚, 秦霈. 星形胶质细胞在中枢神经系统炎性疾病中作用的研究进展[J]. 基础医学与临床, 2023, 43(4): 665-668.
[3]	刘芬, 胡润芳, 茅松, 徐敏, 石文静, 陈凌. 地塞米松减轻过敏性哮喘模型小鼠气道炎性反应[J]. 基础医学与临床, 2023, 43(3): 402-407.
[4]	秦玉春, 邝向东, 蔡林再, 谢景臣, 陈山. 双氢青蒿素减轻慢性阻塞性肺疾病(COPD)模型大鼠肺损伤[J]. 基础医学与临床, 2023, 43(3): 427-432.
[5]	付士祥, 席月, 丁龙坤, 闫曼, 赵俊, 焦玉东, 吴亮. 鲍曼不动杆菌外膜囊泡诱发人单核-巨噬细胞THP-1的炎性反应[J]. 基础医学与临床, 2023, 43(1): 110-115.
[6]	曾颖, 付桂莉. 黄芩提取物抑制IL-22诱导的人角质形成细胞系HaCaT过度增殖[J]. 基础医学与临床, 2023, 43(1): 123-129.
[7]	杨广林, 任丽娟, 陈文静, 熊维军. LncRNA MINCR靶向miR-223抑制LPS诱导的人肺泡上皮细胞系A549损伤和炎性反应[J]. 基础医学与临床, 2023, 43(1): 102-109.
[8]	顾炜, 祝剑平, 吴品雯. 丙泊酚减轻低氧诱导的大鼠肾上腺嗜铬细胞瘤细胞系PC12炎性反应和细胞凋亡[J]. 基础医学与临床, 2023, 43(1): 137-143.
[9]	黄华, 周龙, 姚迪, 许诣. LncRNA PVT1 通过调节miR-214/STAT6 轴减轻哮喘模型小鼠气道炎性反应[J]. 基础医学与临床, 2022, 42(9): 1374-1380.
[10]	谷文浩, 郭飞霞, 徐宇鹏, 陆馨雨, 胡青青. 淫羊藿苷改善重症急性胰腺炎模型大鼠肺损伤[J]. 基础医学与临床, 2022, 42(9): 1400-1405.
[11]	刘珍竹, 李靖, 何丹, 曲鹏. PI3K信号通路调控动脉粥样硬化发生发展的研究进展[J]. 基础医学与临床, 2022, 42(9): 1428-1432.
[12]	杨雄, 靳潇潇, 何文强. 肾上皮细胞损伤与肾结石Randall斑块形成[J]. 基础医学与临床, 2022, 42(9): 1454-1458.
[13]	王珊, 杨华昱, 孙颖, 马清. 老年血液透析患者血清miR-21与T细胞相关[J]. 基础医学与临床, 2022, 42(8): 1188-1193.
[14]	王远卓, 郑清月, 张翰林, 仇文颖, 王涛, 马超. 小胶质细胞在阿尔茨海默病神经炎性反应中作用的研究进展[J]. 基础医学与临床, 2022, 42(8): 1310-1313.
[15]	李潇潇, 舒祥兵, 张莉. 胆固醇代谢与非酒精性脂肪性肝炎的研究进展[J]. 基础医学与临床, 2022, 42(7): 1134-1138.